Home › Funds › GRANDFIELD & DODD, LLC › GILD

GRANDFIELD & DODD, LLC position in GILD

GILEAD SCIENCES INC · Health Care

GRANDFIELD & DODD, LLC reported holding 152,837 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$22.8M, representing 1.22% of its reported portfolio and ranking #29 among its reported holdings. GRANDFIELD & DODD, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)152.84K sh
Reported value held$22.78M
Portfolio Weight1.22%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GRANDFIELD & DODD, LLC's GILD position evolved

GRANDFIELD & DODD, LLC first disclosed a stake in GILD in Q3 2023 at 281,077 shares (US$21.1M). The position peaked in Q1 2025 at 281,732 shares, worth US$31.6M. Across 13 filings, GRANDFIELD & DODD, LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 152,837 shares valued at US$22.8M — a reduction of -1,450 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 281.08K $21.06M New
Q4 2023 280.98K $22.76M Hold
Q1 2024 279.73K $20.49M Hold
Q2 2024 282.96K $19.41M Add
Q3 2024 284.91K $23.89M Add
Q4 2024 283.76K $26.21M Hold
Q1 2025 281.73K $31.57M Reduce
Q2 2025 220.99K $24.50M Reduce
Q3 2025 200.33K $22.24M Reduce
Q4 2025 172.03K $21.11M Reduce
Q1 2026 163.60K $22.80M Reduce
Q2 2026 154.29K $19.49M Reduce
Q3 2026 152.84K $22.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has GRANDFIELD & DODD, LLC held GILD?

GRANDFIELD & DODD, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GRANDFIELD & DODD, LLC's current position in GILD?

As of Q3 2026, GRANDFIELD & DODD, LLC holds 152.84K shares of GILD (GILEAD SCIENCES INC), valued at $22.78M, representing 1.22% of its reported portfolio and ranking #29.

Has GRANDFIELD & DODD, LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), GRANDFIELD & DODD, LLC reduced its position in GILD. The position peaked in Q1 2025 at 281.73K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.